SE8301182D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE8301182D0
SE8301182D0 SE8301182A SE8301182A SE8301182D0 SE 8301182 D0 SE8301182 D0 SE 8301182D0 SE 8301182 A SE8301182 A SE 8301182A SE 8301182 A SE8301182 A SE 8301182A SE 8301182 D0 SE8301182 D0 SE 8301182D0
Authority
SE
Sweden
Prior art keywords
sup
novel compounds
sub
salts
omeprazole
Prior art date
Application number
SE8301182A
Other languages
English (en)
Inventor
A E Brendstrom
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20350251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8301182(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE8301182A priority Critical patent/SE8301182D0/sv
Publication of SE8301182D0 publication Critical patent/SE8301182D0/sv
Priority to IL70985A priority patent/IL70985A/xx
Priority to ZA841202A priority patent/ZA841202B/xx
Priority to DK099584A priority patent/DK160044C/da
Priority to DE8484850066T priority patent/DE3462036D1/de
Priority to AT84850066T priority patent/ATE24907T1/de
Priority to EP84850066A priority patent/EP0124495B1/en
Priority to BG8464457A priority patent/BG44538A3/xx
Priority to DE2001199022 priority patent/DE10199022I2/de
Priority to NO840772A priority patent/NO160204C/no
Priority to IS2887A priority patent/IS1363B6/is
Priority to PH30317A priority patent/PH21352A/en
Priority to SI8410397A priority patent/SI8410397A8/sl
Priority to HU84845A priority patent/HU193557B/hu
Priority to PT78191A priority patent/PT78191B/pt
Priority to AU25257/84A priority patent/AU563842B2/en
Priority to IE514/84A priority patent/IE57326B1/en
Priority to NZ207348A priority patent/NZ207348A/en
Priority to CS841515A priority patent/CS241150B2/cs
Priority to YU397/84A priority patent/YU43345B/xx
Priority to SU843710408A priority patent/SU1314953A3/ru
Priority to CA000448761A priority patent/CA1264751A/en
Priority to DD84260523A priority patent/DD221459A5/de
Priority to GR73990A priority patent/GR79828B/el
Priority to PL1984246492A priority patent/PL142748B1/pl
Priority to ES530242A priority patent/ES530242A0/es
Priority to JP59038921A priority patent/JPS59167587A/ja
Priority to FI840851A priority patent/FI83649C/sv
Priority to GB08405511A priority patent/GB2137616B/en
Priority to ES000530242D priority patent/ES8500934B9/es
Priority to RO84113806A priority patent/RO88721A/ro
Priority to KR1019840001074A priority patent/KR870001005B1/ko
Priority to JO19841425A priority patent/JO1425B1/en
Priority to DZ847097A priority patent/DZ615A1/fr
Priority to MA20272A priority patent/MA20050A1/fr
Priority to US06/854,739 priority patent/US4738974A/en
Priority to MYPI87001982A priority patent/MY102052A/en
Priority to SG14/90A priority patent/SG1490G/en
Priority to HK135/90A priority patent/HK13590A/xx
Priority to SA92120418A priority patent/SA92120418B1/ar
Priority to HRP-397/84A priority patent/HRP930428B1/xx
Priority to LV930867A priority patent/LV5503A3/xx
Priority to LTRP947A priority patent/LT2253B/xx
Priority to BG98585A priority patent/BG60837B2/bg
Priority to LV960280A priority patent/LV5801B4/xx
Priority to NO2000010C priority patent/NO2000010I1/no
Priority to LU90677C priority patent/LU90677I2/fr
Priority to NL300027C priority patent/NL300027I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
SE8301182A 1983-03-04 1983-03-04 Novel compounds SE8301182D0 (sv)

Priority Applications (48)

Application Number Priority Date Filing Date Title
SE8301182A SE8301182D0 (sv) 1983-03-04 1983-03-04 Novel compounds
IL70985A IL70985A (en) 1983-03-04 1984-02-16 Omeprazole salts,their preparation and pharmaceutical compositions containing them
ZA841202A ZA841202B (en) 1983-03-04 1984-02-17 Novel compounds
DK099584A DK160044C (da) 1983-03-04 1984-02-24 Salte af omeprazol, farmaceutisk praeparat indeholdende disse og deres anvendelse
DE8484850066T DE3462036D1 (en) 1983-03-04 1984-02-28 Omeprazole salts
AT84850066T ATE24907T1 (de) 1983-03-04 1984-02-28 Omeprazol-salze.
EP84850066A EP0124495B1 (en) 1983-03-04 1984-02-28 Omeprazole salts
BG8464457A BG44538A3 (en) 1983-03-04 1984-02-28 Method for preparing salts of 5- metoxy- 2- big bracket [(4- metoxy- 3, 5- dimethyl- 2- pyridinyl)- methyl] sulphonyl- 1h- benzimidazol
DE2001199022 DE10199022I2 (de) 1983-03-04 1984-02-28 Omeprazol-Salze.
NO840772A NO160204C (no) 1983-03-04 1984-02-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive alkalisalter av 5-metoksy-2(((4-metoksy-3,5-dimetyl-2-pyridinyl)-metyl)-sulfinyl)-1h-benzimidazol.
IS2887A IS1363B6 (is) 1983-03-04 1984-03-01 Framleiðsla á nýjum omeprazól-söltum
PH30317A PH21352A (en) 1983-03-04 1984-03-01 Salts of 5-methoxy)((4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl)sulfinyl)-1h-benzimidazole composition containing same and use thereof
SI8410397A SI8410397A8 (sl) 1983-03-04 1984-03-02 Postopek za dobivanje novih soli omeprazola
HU84845A HU193557B (en) 1983-03-04 1984-03-02 Process for preparing salts of omeprazole
PT78191A PT78191B (en) 1983-03-04 1984-03-02 Process for preparing novel salts of omeprazole and of pharmaceutical compositions containing the same
AU25257/84A AU563842B2 (en) 1983-03-04 1984-03-02 Omeprazole salts
IE514/84A IE57326B1 (en) 1983-03-04 1984-03-02 Salts of omeprazole
NZ207348A NZ207348A (en) 1983-03-04 1984-03-02 Omeprazole-(5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl)-sulfinyl)-1h-benzimidazole)
CS841515A CS241150B2 (en) 1983-03-04 1984-03-02 Method of 5-methoxy-2-(/4-methoxy-3,5-dimethyl-2-pyridinyl/-methyl/)-1,h-benzimidazole's new salts production
YU397/84A YU43345B (en) 1983-03-04 1984-03-02 Process for obtaining new salts of omeprazole
SU843710408A SU1314953A3 (ru) 1983-03-04 1984-03-02 Способ получени солей омепразола
CA000448761A CA1264751A (en) 1983-03-04 1984-03-02 Base addition salts of omeprazole
DD84260523A DD221459A5 (de) 1983-03-04 1984-03-02 Verfahren zur herstellung von omeprazolsalzen
GR73990A GR79828B (sv) 1983-03-04 1984-03-02
PL1984246492A PL142748B1 (en) 1983-03-04 1984-03-02 Process for preparing novel salts of 5-methoxy-2-//(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl/sulfinyl/ -1h-benzimidazole
ES530242A ES530242A0 (es) 1983-03-04 1984-03-02 Un procedimiento para preparar sales de un derivado de imidazol
JP59038921A JPS59167587A (ja) 1983-03-04 1984-03-02 オメプラゾ−ル化合物
FI840851A FI83649C (sv) 1983-03-04 1984-03-02 Förfarande för framställning av farmakologiskt aktiva omeprazolsalter
GB08405511A GB2137616B (en) 1983-03-04 1984-03-02 Novel compounds
ES000530242D ES8500934B9 (es) 1983-03-04 1984-03-02 Un procedimiento para preparar sales de un derivado de imidazol.
RO84113806A RO88721A (ro) 1983-03-04 1984-03-02 Procedeu pentru prepararea sarurilor de 5-metoxi-2-(4-metoxi-3,5-dimetil-2-piridinil)-metil/-sulfinil)-1h-benzimidazol
KR1019840001074A KR870001005B1 (ko) 1983-03-04 1984-03-03 오메프라졸염의 제조 방법
JO19841425A JO1425B1 (en) 1983-03-04 1984-03-03 New vehicles
DZ847097A DZ615A1 (fr) 1983-03-04 1984-03-04 Composés nouveaux.
MA20272A MA20050A1 (fr) 1983-03-04 1984-03-05 Nouveaux composes concernant des nouveaux sels d"omeprazole.
US06/854,739 US4738974A (en) 1983-03-04 1986-04-21 Base addition salts of omeprazole
MYPI87001982A MY102052A (en) 1983-03-04 1987-09-26 Base addition salts of omeprazole
SG14/90A SG1490G (en) 1983-03-04 1990-01-10 Omeprazole salts
HK135/90A HK13590A (en) 1983-03-04 1990-02-22 Omeprazole salts
SA92120418A SA92120418B1 (ar) 1983-03-04 1992-03-09 أملاح الاوميبرازول omeprazole
HRP-397/84A HRP930428B1 (en) 1983-03-04 1993-03-22 Process for the preparation of omeprazole new salts
LV930867A LV5503A3 (lv) 1983-03-04 1993-06-30 Panemiens omeprazola salu iegusanai
LTRP947A LT2253B (lt) 1983-03-04 1993-09-06 Omeprazolo drusku gavimo budas
BG98585A BG60837B2 (bg) 1983-03-04 1994-02-25 Соли на омепразола
LV960280A LV5801B4 (lv) 1983-03-04 1996-07-18 Omeprazola pievienotas bazes sali
NO2000010C NO2000010I1 (no) 1983-03-04 2000-10-05 Farmasøytisk akseptable salter av esomeprazol
LU90677C LU90677I2 (fr) 1983-03-04 2000-11-15 Esomeprazole et ses sels et d-riv-s pharmaceutiquement acceptables (nexiam)
NL300027C NL300027I2 (nl) 1983-03-04 2000-11-17 Omeprazole-derivaten.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8301182A SE8301182D0 (sv) 1983-03-04 1983-03-04 Novel compounds

Publications (1)

Publication Number Publication Date
SE8301182D0 true SE8301182D0 (sv) 1983-03-04

Family

ID=20350251

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8301182A SE8301182D0 (sv) 1983-03-04 1983-03-04 Novel compounds

Country Status (43)

Country Link
US (1) US4738974A (sv)
EP (1) EP0124495B1 (sv)
JP (1) JPS59167587A (sv)
KR (1) KR870001005B1 (sv)
AT (1) ATE24907T1 (sv)
AU (1) AU563842B2 (sv)
BG (2) BG44538A3 (sv)
CA (1) CA1264751A (sv)
CS (1) CS241150B2 (sv)
DD (1) DD221459A5 (sv)
DE (2) DE10199022I2 (sv)
DK (1) DK160044C (sv)
DZ (1) DZ615A1 (sv)
ES (2) ES530242A0 (sv)
FI (1) FI83649C (sv)
GB (1) GB2137616B (sv)
GR (1) GR79828B (sv)
HK (1) HK13590A (sv)
HR (1) HRP930428B1 (sv)
HU (1) HU193557B (sv)
IE (1) IE57326B1 (sv)
IL (1) IL70985A (sv)
IS (1) IS1363B6 (sv)
JO (1) JO1425B1 (sv)
LT (1) LT2253B (sv)
LU (1) LU90677I2 (sv)
LV (2) LV5503A3 (sv)
MA (1) MA20050A1 (sv)
MY (1) MY102052A (sv)
NL (1) NL300027I2 (sv)
NO (2) NO160204C (sv)
NZ (1) NZ207348A (sv)
PH (1) PH21352A (sv)
PL (1) PL142748B1 (sv)
PT (1) PT78191B (sv)
RO (1) RO88721A (sv)
SA (1) SA92120418B1 (sv)
SE (1) SE8301182D0 (sv)
SG (1) SG1490G (sv)
SI (1) SI8410397A8 (sv)
SU (1) SU1314953A3 (sv)
YU (1) YU43345B (sv)
ZA (1) ZA841202B (sv)

Families Citing this family (159)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0204215B1 (en) 1985-05-24 1993-08-11 G.D. Searle & Co. 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines
US5869513A (en) * 1985-05-24 1999-02-09 G. D. Searle & Co. 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
JPS62277322A (ja) * 1986-02-13 1987-12-02 Takeda Chem Ind Ltd 安定化された腸溶性抗潰瘍固形組成物
US6749864B2 (en) 1986-02-13 2004-06-15 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US5433959A (en) * 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4687775A (en) * 1986-07-17 1987-08-18 G. D. Searle & Co. 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4721718A (en) * 1986-08-18 1988-01-26 G. D. Searle & Co. 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
JP2536173B2 (ja) * 1988-08-18 1996-09-18 武田薬品工業株式会社 注射剤
KR920003928B1 (ko) * 1988-09-20 1992-05-18 히사미쯔세이야꾸 가부시기가이샤 신규의 디벤즈[b,e]옥세핀유도체
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
JP2694361B2 (ja) * 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
ES2026761A6 (es) * 1990-10-31 1992-05-01 Genesis Para La Investigacion Procedimiento de obtencion del omeprazol.
ATE144421T1 (de) * 1992-07-28 1996-11-15 Astra Ab Injizierbares arzneimittel und satz, die omoprazol oder verwandte verbindungenenthalten
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
TW359614B (en) * 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
TW280770B (sv) 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
PL180395B1 (pl) 1994-07-08 2001-01-31 Astra Ab Doustna farmaceutyczna tabletkowana postac dawkowania oraz sposób wytwarzania doustnej farmaceutycznej tabletkowanej postaci dawkowania PL PL PL PL PL PL PL PL PL PL
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
CN1042423C (zh) * 1995-05-25 1999-03-10 常州市第四制药厂 奥美拉唑盐水合物及其制备方法
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE9702000D0 (sv) * 1997-05-28 1997-05-28 Astra Ab New pharmaceutical formulation
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
US6747155B2 (en) 1997-05-30 2004-06-08 Astrazeneca Ab Process
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
SI9700186B (sl) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
DE19801811B4 (de) * 1998-01-19 2004-12-23 Stada Arzneimittel Ag Pharmazeutische Zubereitung zur oralen Verabreichung
DK173431B1 (da) 1998-03-20 2000-10-23 Gea Farmaceutisk Fabrik As Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
US6048981A (en) * 1998-04-22 2000-04-11 Torcan Chemical Ltd. Magnesium omeprazole and process for its preparation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9803772D0 (sv) 1998-11-05 1998-11-05 Astra Ab Pharmaceutical formulation
IL142703A (en) * 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
UA72748C2 (en) 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
SE9900274D0 (sv) * 1999-01-28 1999-01-28 Astra Ab New compound
IL130602A0 (en) 1999-06-22 2000-06-01 Dexcel Ltd Stable benzimidazole formulation
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6228400B1 (en) 1999-09-28 2001-05-08 Carlsbad Technology, Inc. Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
SE9903831D0 (sv) * 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
CA2290893C (en) 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
EP1706397A4 (en) * 2000-05-15 2007-08-01 Ranbaxy Lab Ltd AMORPHOUS FORM OF OMEPRAZOLE SALTS
US6306435B1 (en) 2000-06-26 2001-10-23 Yung Shin Pharmaceutical Industrial Co. Ltd. Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
CA2386716C (en) * 2002-05-17 2012-07-24 Bernard Charles Sherman Magnesium salt of s-omeprazole
DE60123800T2 (de) * 2000-08-04 2007-10-11 Takeda Pharmaceutical Co. Ltd. Salze von benzimidazol-derivaten und deren verwendung
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
ES2286408T3 (es) * 2002-03-05 2007-12-01 Astrazeneca Ab Sales de alquilamonio de omeprazol e esomeprazol.
TW200410955A (en) 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
AU2003262992A1 (en) 2002-08-30 2004-03-19 Reddy's Laboratories Limited Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
WO2004037253A1 (en) * 2002-10-22 2004-05-06 Ranbaxy Laboratories Limited Amorphous form of esomeprazole salts
JP2006513239A (ja) * 2002-12-23 2006-04-20 セルテック アメリカズ， インコーポレイテッド 酸不安定性薬剤含有組成物
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
JP4891064B2 (ja) * 2003-02-24 2012-03-07 田辺三菱製薬株式会社 テナトプラゾールの光学異性体および治療におけるその使用
WO2004085424A1 (ja) * 2003-03-24 2004-10-07 Eisai Co., Ltd. スルホキシド誘導体またはその塩のアモルファスの製造方法
WO2004099181A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Barium salt of benzimidazole derivative
WO2004099182A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Zinc salt of (s)-omeprazole
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
DK1651217T3 (da) * 2003-07-23 2008-06-16 Nycomed Gmbh Alkalisalte af protonpumpeinhibitorer
CN100457104C (zh) * 2003-07-23 2009-02-04 尼科梅德有限责任公司 质子泵抑制剂的碱性盐
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
SE0302382D0 (sv) * 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
SE0400410D0 (sv) 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1748998B1 (en) * 2004-05-28 2010-01-27 Hetero Drugs Limited A novel stereoselective synthesis of benzimidazole sulfoxides
US20050267159A1 (en) * 2004-05-28 2005-12-01 Aaipharma, Inc. Magnesium complexes of S-omeprazole
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
KR20130038949A (ko) 2004-06-24 2013-04-18 아스트라제네카 아베 에소메프라졸 나트륨염의 제조에서 사용하기 위한 결정 변형의 제조를 위한 신규한 방법
US20060024362A1 (en) * 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
EP1775292B1 (en) 2004-08-06 2012-06-27 Eisai R&D Management Co., Ltd. Salts of benzimidazole derivative with amines and process for production thereof
EP1830823A2 (en) 2004-12-23 2007-09-12 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and process of preparation thereof
WO2006073779A1 (en) * 2004-12-30 2006-07-13 Transform Phamaceuticals, Inc. Novel omeprazole forms and related methods
EP1845982A2 (en) * 2005-02-02 2007-10-24 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions prepared by non-aqueous layering process
RU2007145207A (ru) * 2005-05-06 2009-06-20 Гленмарк Фармасьютикалз Лимитед (In) Стронциваемая соль эзомепразола, способ ее получения и содержащее ее фармацевтические композиции
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
EP1907375B1 (en) * 2005-06-08 2013-07-24 LEK Pharmaceuticals d.d. Crystalline solvate of omeprazole sodium
US7563812B2 (en) 2005-06-15 2009-07-21 Hetero Drugs Limited Amorphous esomeprazole hydrate
US20070043085A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of amorphous form of neutral esomeprazole
RU2372345C1 (ru) * 2005-10-26 2009-11-10 Ханми Фарм. Ко., Лтд. Стронциевая соль s-омепразола или ее гидрат, способ их получения и содержащая их фармацевтическая композиция
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
EP1785135A1 (en) * 2005-11-10 2007-05-16 Laboratorios Del Dr. Esteve, S.A. New stabilized galenic formulations comprising lansoprazole and their preparation
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
ES2281292B1 (es) * 2006-03-08 2008-06-16 Quimica Sintetica S.A. Nuevas sales de esomeprazol. procedimiento de preparacion y composiciones farmaceuticas que las comprenden.
DE602007010926D1 (de) * 2006-06-07 2011-01-13 Astrazeneca Ab Neues verfahren zur herstellung von ammoniumsalzen von esomeprazol
US7786309B2 (en) 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
AU2007278986B2 (en) 2006-07-25 2010-09-16 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI
GB2459393B (en) 2006-10-05 2010-09-08 Santarus Inc Novel capsule formulation for the proton pump inhibitor omeprazole
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
MX2009004475A (es) 2006-10-27 2009-08-12 Univ Missouri Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
ZA200904573B (en) 2006-12-22 2010-09-29 Ironwood Pharmaceuticals Inc Compositions comprising bile acid sequestrants for treating esophageal disorders
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
EP2186807B1 (en) * 2007-02-21 2015-01-07 Cipla Limited Process for the preparation of esomeprazole magnesium dihydrate
EP2152691B1 (en) * 2007-06-07 2011-11-23 Aurobindo Pharma Limited An improved process for preparing an optically active proton pump inhibitor
WO2009047775A2 (en) * 2007-10-08 2009-04-16 Hetero Drugs Limited Polymorphs of esomeprazole salts
US8247440B2 (en) 2008-02-20 2012-08-21 Curators Of The University Of Missouri Composition comprising omeprazole, lansoprazole and at least one buffering agent
US8911787B2 (en) 2008-02-26 2014-12-16 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and process of preparation thereof
WO2009137648A1 (en) * 2008-05-09 2009-11-12 Aptapharma, Inc. Multilayer proton pump inhibitor tablets
US20090280173A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Omeprazole Tablets
EP2147918A1 (en) * 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Process for the preparation of S-omeprazole magnesium in a stable form
CH699302B1 (de) * 2008-08-11 2012-03-15 Mepha Gmbh Orale pharmazeutische Formulierung für Omeprazol, enthaltend eine spezifische Trennschicht.
JP4906817B2 (ja) * 2008-08-29 2012-03-28 セイコークロック株式会社 装飾装置及びからくり時計
JP2012502015A (ja) 2008-09-09 2012-01-26 アストラゼネカ・アクチエボラーグ 必要がある患者に医薬組成物を送達するための方法
WO2010058409A2 (en) * 2008-11-18 2010-05-27 Hetero Research Foundation Optical purification of esomeprazole
WO2010122583A2 (en) 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
WO2010151697A1 (en) * 2009-06-25 2010-12-29 Pozen Inc. Method for treating a patient in need of aspirin therapy
EP2499125B1 (en) 2009-11-12 2016-01-27 Hetero Research Foundation Process for the resolution of omeprazole
EP2345408A3 (en) 2010-01-08 2012-02-29 Dr. Reddy's Laboratories Ltd. Acid labile drug formulations
FR2967353B1 (fr) * 2010-11-16 2013-08-16 Centre Nat Rech Scient Derives de quinolinone
CN102351846B (zh) * 2011-09-07 2012-08-22 周晓东 一种新的奥美拉唑钠化合物及其药物组合物
WO2013081566A1 (en) 2011-11-25 2013-06-06 Mahmut Bilgic A formulation comprising benzimidazole
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
WO2013108068A1 (en) 2012-01-21 2013-07-25 Jubilant Life Sciences Limited Process for the preparation of 2-pyridinylmethylsulfinyl benzimidazoles, their analogs and optically active enantiomers
US20160015644A1 (en) 2013-01-15 2016-01-21 Ironwood Pharmaceuticals, Inc. Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant
WO2014127025A1 (en) * 2013-02-13 2014-08-21 Reza Fathi Pharmaceutical compositions for the treatment of helicobacter pylori
GB201306720D0 (en) 2013-04-12 2013-05-29 Special Products Ltd Formulation
EP2929885A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and proton pump inhibitors
US10130618B2 (en) 2014-04-11 2018-11-20 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical combinations of dabigatran and proton pump inhibitors
CN104045627A (zh) * 2014-05-21 2014-09-17 丽珠医药集团股份有限公司 一种奥美拉唑纯化方法
US20180015118A1 (en) 2015-02-03 2018-01-18 Ironwood Pharmaceuticals, Inc. Methods of treating upper gastrointestinal disorders in ppi refractory gerd
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234058A (sv) * 1968-10-21 1971-06-03
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
CA1085392A (en) * 1976-03-25 1980-09-09 Masayuki Narisada Arylmalonamido-1-oxadethiacephalosporins
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects

Also Published As

Publication number Publication date
IE57326B1 (en) 1992-07-29
MY102052A (en) 1992-03-31
DE10199022I1 (de) 2001-06-21
GB2137616B (en) 1986-11-12
MA20050A1 (fr) 1984-10-01
FI83649C (sv) 1991-08-12
IL70985A (en) 1987-10-20
DD221459A5 (de) 1985-04-24
AU2525784A (en) 1984-09-06
NO160204C (no) 1989-03-22
LV5801A4 (lv) 1997-02-20
JPS59167587A (ja) 1984-09-21
CS241150B2 (en) 1986-03-13
CS151584A2 (en) 1985-06-13
SG1490G (en) 1990-07-13
GR79828B (sv) 1984-10-31
NO840772L (no) 1984-09-05
JO1425B1 (en) 1988-03-10
US4738974A (en) 1988-04-19
DK99584A (da) 1984-09-05
SI8410397A8 (sl) 1995-10-31
ES8500934A1 (es) 1984-11-01
PT78191B (en) 1986-08-05
EP0124495A3 (en) 1985-05-15
IE840514L (en) 1984-09-04
PL246492A1 (en) 1985-02-27
DZ615A1 (fr) 2004-09-13
ZA841202B (en) 1984-10-31
GB2137616A (en) 1984-10-10
BG60837B2 (bg) 1996-04-30
JPH0313233B2 (sv) 1991-02-22
DK160044C (da) 1991-06-10
YU39784A (en) 1986-12-31
LV5801B4 (lv) 1997-12-20
PT78191A (en) 1984-04-01
LV5503A3 (lv) 1994-03-10
HRP930428B1 (en) 1996-04-30
ES530242A0 (es) 1984-11-01
DE3462036D1 (en) 1987-02-19
DK99584D0 (da) 1984-02-24
NL300027I2 (nl) 2001-07-02
EP0124495B1 (en) 1987-01-14
YU43345B (en) 1989-06-30
HU193557B (en) 1987-10-28
LU90677I2 (fr) 2001-02-05
NO160204B (no) 1988-12-12
NO2000010I1 (no) 2000-10-05
EP0124495A2 (en) 1984-11-07
PH21352A (en) 1987-10-15
DE10199022I2 (de) 2004-07-01
DK160044B (da) 1991-01-21
FI83649B (fi) 1991-04-30
IS1363B6 (is) 1989-05-25
PL142748B1 (en) 1987-11-30
IS2887A7 (is) 1984-09-05
KR840008014A (ko) 1984-12-12
GB8405511D0 (en) 1984-04-04
CA1264751A (en) 1990-01-23
FI840851A (fi) 1984-09-05
FI840851A0 (fi) 1984-03-02
ES8500934B9 (es) 2012-01-03
NZ207348A (en) 1986-10-08
NL300027I1 (nl) 2001-02-01
HK13590A (en) 1990-03-02
RO88721A (ro) 1986-04-30
ATE24907T1 (de) 1987-01-15
KR870001005B1 (ko) 1987-05-18
AU563842B2 (en) 1987-07-23
SA92120418B1 (ar) 2003-12-23
SU1314953A3 (ru) 1987-05-30
BG44538A3 (en) 1988-12-15
LT2253B (lt) 1993-11-15

Similar Documents

Publication Publication Date Title
SE8301182D0 (sv) Novel compounds
SE8405588D0 (sv) New compounds